Carotenoids, the carotenes and xanthophylls, are essential components in human nutrition. b, b-carotene-9 0 , 10 0 -oxygenase 2 (BCO2), also named as b, b-carotene-9 0 , 10'-dioxygenase 2 (BCDO2) catalyzes the asymmetrical cleavage of carotenoids, whereas b, b-carotene-15, 15 0 -monooxygenase (BCMO1) conducts the symmetrical cleavage of pro-vitamin A carotenoids into retinoid. Unlike BCMO1, BCO2 has a broader substrate specificity and has been considered an alternative way to produce vitamin A. In contrast to BCMO1, a cytoplasmic protein, BCO2 is located in the inner mitochondrial membrane. The difference in cellular compartmentalization may reflect the different substrate specificity and physiological functions with respect to BCMO1 and BCO2. The BCO2 gene mutations are proven to be associated with yellow color of skin and fat tissue and milk in livestock. Mutation in intron 2 of BCO2 gene is also supposed to be related to the expression of IL-18, a pro-inflammatory cytokine associated with obesity, cardiovascular diseases, and type 2 diabetes. Further, BCO2 is associated with the development of mitochondrial oxidative stress, macular degeneration, anemia, and hepatic steatosis. This review of the literature will mostly address recent updates regarding the role of BCO2 in carotenoid metabolism, and discuss the potential impacts of BCO2 protein and the mutations in mammalian diseases.
Introduction
Carotenoids are 40-carbon lipophilic pigments, which can be synthesized from plants, bacteria, and fungi. 1 Carotenoids can be classified into two groups: the xanthophylls, which contain oxygenated groups, and the carotenes, which are only hydrocarbons without oxygenated groups and less polar than the xanthophylls. 2, 3 Carotenoids present several important functions in human physiology. First, carotenoids, such as zeaxanthin and lutein, function as antioxidants and filters of blue light. These macular pigments decrease chromatic aberration to protect the retina against light induced damage, which is initiated by the formation of reactive oxygen species (ROS) during a photosensitized reaction. 4, 5 Second, well-known provitamin A carotenoids such as b-carotene are the precursors of retinoid, which are important for eye function. 1 For most of the world, provitamin A carotenoids are the major dietary source of vitamin A. 6 Vitamin A deficiency leads to childhood blindness and increases morbidity in children, especially in developing countries. 7 The amount of vitamin A produced from carotenoids is mainly based on two factors, the absorption and metabolism of carotenoid intake. 8, 9 The mode of vitamin A production has been suggested to be the symmetric oxidative cleavage of provitamin A carotenoids, such as b-carotene, a-carotene, and b-cryptoxanthin. The gene encoding this symmetric cleavage enzyme b, b-carotene-15, 15 0 -monooxygenase (BCMO1) was cloned from several species, including human, mouse, chicken, and Drosophila. 10, 11 However, recent biochemical studies showed that provitamin A carotenoids can also be catalyzed into apocarotenoids, which is different from retinoid. This eccentric cleavage, which was conducted by b, bcarotene-9 0 , 10 0 -oxygenase 2 (BCO2), also named as b, b-carotene-9 0 , 10 0 -dioxygenase 2 (BCDO2), has been considered as an alternative source of vitamin A production. 12, 13 Different from BCMO1, BCO2 can also metabolize non-provitamin A carotenoids including lutein and other xanthophylls. 14, 15 BCMO1 and BCO2 have different intracellular localizations as BCMO1 is located in the cytoplasm, 11 while BCO2 is located in the inner mitochondrial membrane. 16 The different cellular compartments may reflect the different substrate specificity and physiological functions with respect to BCMO1 and BCO2. Therefore, in this review, we will focus on the enzymatic activity of BCO2 in carotenoid metabolism, genetic characteristics and mutations of BCO2, and finally protein function of BCO2 in nutrition.
Carotenoid metabolism by BCMO1 and BCO2
Carotenoids are natural fat-soluble pigments synthesized in plants, bacteria, and fungi, which play important roles in animal and plant physiology. For carotenoid metabolism, the existence of carotenoid cleavage enzymes was discussed as early as 1965, although the first cleavage enzyme VP14 was not identified until 1997. 17 In animals, there are two carotenoid cleavage enzymes that have been identified. The first is BCMO1, which catalyzes the centric cleavage at 15, 15 0 double bond of b-carotene, forming two molecules of all-trans retinal. This all-trans retinal can be irreversibly oxidized into retinoic acid or reversibly reduced into retinol ( Figure 1 ). 10, 11 The second enzyme is BCO2, which participates in eccentric cleavage of b-carotene at 9 0 , 10 0 and/or 9, 10 double bond, forming apocarotenoid, which is different from retinoid, including b-apo-10 0 -carotenal and b-ionone ( Figure 2 ). Although BCMO1 functions as a major enzyme in vitamin A production, BCO2 is considered to be an alternative pathway for forming vitamin A. 18, 19 Both BCMO1 and BCO2 are family members of nonheme iron oxygenases, which are important in many physiological processes in both animals and plants. 20 Besides BCMO1 and BCO2, the retinal pigment epithelium protein of 65 kDa (RPE65) was also included in this nonheme iron oxygenase family, which is crucial for vision as well. 21, 22 In a recombinant human BCMO1 study, BCMO1 was found to cleave pro-vitamin A carotenoids, which contain at least one nonsubstituted b-ionone ring, such as a-carotene, b-carotene, or b-cryptoxanthin, but fails to catalyze the cleavage of non-provitamin A carotenoids, such as zeaxanthin, lutein, or lycopene. 11 BCMO1 was found to be present in the intestinal mucosa, where it facilitates the cleavage of a majority of the carotenoids. BCMO1 was also present in the classical steroidogenic cells, which are sensitive to vitamin A deficiency. 23 BCMO1 was therefore proposed to be present in extra-intestinal tissues as a backup system for the local synthesis of vitamin A when intake was decreased. 24 In mice, BCMO1 was found to play key roles in retinoid production. 25 In humans, a heterozygotic mutation in BCMO1 gene led to the increased plasma levels of b-carotene and decreased plasma concentrations of retinoid. 26 The expression and activity of BCO2 has been verified in humans, 23 cattle, 27 sheep, 9 and chicken. 28 BCO2 is highly expressed in hepatocytes, which are important for uptake and processing of retinol. 29 Except for b-carotene, lutein, lycopene, b-cryptoxanthin, and zeaxanthin are all specific substrates for BCO2. For instance, BCO2 could cleave the acyclic carotenoid, lycopene. However, only the 13-cis-and 5-cis-isomers of lycopene could be cleaved by BCO2. 30 BCO2 was also found to cleave lutein at both 9 0 , 10 0 and 9, 10 double bond, leading to the formation of b-ionone, bapo-10 0 -carotenal and apo-10, 10 0 -carotenedialdehyde. 31 Interestingly, the production of b-apo-10 0 -carotenal was significantly affected by the concentration of ferrous iron. When the concentration of ferrous iron decreased from 78% to 67%, the formation of b-apo-10 0 -carotenal was significantly decreased, showing that iron was a necessary cofactor for this enzymatic cleavage. 19 Therefore, these studies demonstrate that BCO2 displays a much broader substrate specificity for carotenoid metabolism as compared to BCMO1. 16, 32, 33 
BCO2 genetics
In the entire genome of Drosophila, only BCMO1 gene is found, which is encoded by the ninaB gene. However, in vertebrates, two other genes besides BCMO1, BCO2 and RPE65, are found. Based on the deduced amino acid sequence, BCMO1, BCO2, and RPE65 share approximately 40% overall sequence identity. 34 Additionally, there are four histidine residues within the amino acid sequence, conserved in their positions along with several highly conserved regions which can be viewed as protein family motifs. 35 According to functional assays in vitro, two tyrosine residues, Y326 and Y235, are reported to be important for the activity of mouse BCMO1. Y235 is completely conserved in BCMO1, BCO2, and RPE65. However, Y326 is well conserved in all BCMO1 homologues and changed to tryptophan and glutamine in all RPE65 and most BCO2, respectively. 36 In humans, BCO2 genomically maps to chromosomal position 11q23.1. So far 19 different splice variants of human BCO2 have been identified, 9 of which are protein coding (http:// www.ensemble.org). Among all of the 11 identified exonic SNPs in the open reading frame of human BCO2, only rs17113607 and rs10891338 have minor allele frequencies over 5%, according to HapMap (http://hapmap.ncbi.nlm.nih.gov). This indicates that splice variants could be important in introducing large inter-individual differences in BCO2 activity. For example, the intronic SNP rs2115753 at the locus of BCO2 was correlated with IL-18 concentration. 37 The overall human BCO2 gene spans 11 exons across 42.5 kilobases (kb) on chromosomal 11q23.1 (Figure 3 ). The coding sequence is 1424 bases (Accession Number is NM_001256400). According to the genetic analysis of the 5 0 UTR domain of BCO2, several regulatory transcription factor binding sites are found in the BCO2 gene promoter section, including TATA-binding protein (TBP), activator protein family (AP), and signal transducer and activator of transcription family (STAT) family ( Figure 4 ). AP is a family of transcription factors, composed of proteins including c-Jun, c-Fos, Jun dimerization partner (JDP), and activating transcription factor (ATF). Regulation of the human BCO2 gene expression by AP is found in response to a variety of stimuli, including growth factors, cytokines, stress, and viral and bacterial infections. AP also participates in several cellular processes, such as proliferation, differentiation, and apoptosis. 38, 39 These characteristics in the human BCO2 gene promotor region indicate that the human BCO2 gene may be a stress responsive gene and participates in several important cellular processes.
Compared with the mouse BCO2 gene, in exon 3, there is an insertion of GGT AAA GCT GCA in the human BCO2 gene. This insertion DNA sequence is a coding sequence, which codes an amino acid sequence in human BCO2 protein. In this way, the major difference between human BCO2 enzyme and mouse BCO2 enzyme is the existence of 4 amino acid residues GKAA in human BCO2. This specific insertion of GKAA is unique to primates and is absent in sheep, rats, mice, cows, and ferrets according to the NCBI protein database search. This GKAA sequence is also absent in mouse and human RPE65, which can cleave all-trans-retinyl esters. 40 The effects of BCO2 gene mutation in animals
The deficiency of BCO2 was found to be associated with carotenoids accumulating in the adipose tissues, such as subcutaneous adipose tissue, 41 which leads to occurrence of yellow fat in sheep, 42, 43 cow, 27 and chicken. 28 In the yellow fat experimental sheep, the BCO2 coding region was sequenced and the nonsense mutation of BCO2 was found in nucleotide position 196 (c.196C > T). This nonsense mutation introduced a stop codon in position 66 of the amino acid, while the full-length protein BCO2 in sheep contains 575 amino acids. It was hypothesized that the mutant in the BCO2 gene forms a nonfunctional enzyme. 44 In cows, BCO2 mutation was associated with the yellow color of the adipose tissue and milk, which was mainly caused by deposition of carotenoids. 27 Association analysis showed that there were significant differences among cattle with different BCO2 genotypes in concentration of b-carotene and color of subcutaneous fat. Compared with genotypes of BCO2 AA, GA, and GG, the animals with AA had a higher concentration of b-carotene and more yellow fat than those animals with GG or GA genotype. The A allele which is in bovine BCO2 exon 3 is a nonsense mutation. As the full length of BCO2 protein in cattle is 530 amino acids, the change in this allele results in a different polypeptide with presumably a loss in BCO2 enzyme function. 27 The data showed that there is a strong link between this BCO2 SNP and fat color in cattle.
BCO2 gene mutation affects IL-18 levels in humans IL-18, found in Kupffer cells and macrophages, is an important pro-inflammatory cytokine which plays key roles in innate and acquired immunities. It has been shown that the plasma concentration of IL-18 is associated with different diseases, including atherosclerosis, cardiovascular diseases, and type 2 diabetes. 37, 45, 46 In humans, variants at the BCO2 locus were associated with IL-18 levels, but not carotenoid levels in either plasma or macula. 37 A two-stage genome-wide association study among women of the Women's Genome Health Study (WGHS) and European ancestry from the Nurses' Health Study (NHS) was performed to test this association between BCO2 and IL-18. In the stage of discovery, seven SNPs located at the IL18-BCO2 locus were significantly related to concentrations of IL-18. According to these combined analyses, SNPs rs2115763, rs7106524, and rs1834481 were found to show significant association between the BCO2 and IL-18 genes. SNP rs2115763 was found to be the strongest among these three SNPs. Further selection analysis showed that SNPs rs1834481 and rs2115763 were independently associated with IL-18 levels. Variation of 2.9% plasma levels of IL-18 could be explained together by these two SNPs. SNP rs2115763, which presents the strongest association, is located in intron two of the BCO2 gene and also in the same location of the IL-18 gene. 37 It is reported that the IL-18 level was significantly lower in the BCO2 knockout mice. 30 However, the underlying mechanism between the IL-18 level and SNP rs2115763 in the BCO2 gene is unknown. SNP rs2115763 might regulate transcription of the IL-18 gene directly, as the BCO2 gene is upstream of the IL-18 gene. Another possibility is that SNP rs2115763 is an indicator of IL-18 gene functional mutation, affecting plasma levels of IL-18. 45, 46 The function of BCO2 in nutrition Genetic studies in sheep, cows, and chickens revealed that BCO2 gene mutations could alter the homeostasis of carotenoid metabolism. This was also confirmed in a mouse model. In accordance with the subcellular location of BCO2 (in the inner mitochondrial membrane), carotenoids were found to be accumulated in mitochondria and to impair respiration. 16 In hepatic mitochondria, accumulated carotenoids lead to mitochondrial dysfunction, such as reducing ADP-dependent respiration rates. This dysfunction was associated with cell signaling pathways related to oxidative stress and diseases. 14 Therefore, BCO2 functions as a key regulator of preventing the adverse effect caused by excess carotenoids. However, we are still at the early stage of understanding the importance of BCO2 in health and disease. The advanced knowledge of BCO2 function might help us to better understand the biochemical, developmental, and physiological roles of carotenoids.
Function of BCO2 on eyes
Carotenoids, such as lutein and zeaxanthin, accumulated in the retina and circulation system, were supposed to be associated with common eye diseases, such as diabetic retinopathy, age-related macular degeneration (AMD) and so on. 9, 47, 48 Researchers tested various genes related to zeaxanthin and lutein status for association with AMD in the Age-Related Eye Disease Study (CAREDS). Four hundred twenty-four SNPs from 24 candidate genes were genotyped in 1663 of 2005 CAREDS participants. After adjusting for ancestry and age, 24 variants from five genes (BCMO1, BCO2, NPCL1L1, ABCG8, and FADS2) were related to AMD independently. SNP rs2250417 in BCO2 is one of the strongest in statistical significance for carotenoid-candidate genes association with AMD. 49 The two minor alleles for SNP rs2250417 in BCO2 accounted for increasing risk by almost 50% for AMD. 49 Carotenoids with a hydroxylated b-ionone ring including cryptoxanthin and lutein and zeaxanthin are substrates for BCO2, which is located in the mitochondria. As discussed above, mutations of BCO2 might cause an accumulation of zeaxanthin and lutein in the skin of livestock to form yellow fat. However, in this CAREDS, the variants of BCO2 were not related to concentrations of lutein and zeaxanthin in the macular pigment and blood. These findings suggested that BCO2 mutations had tissue specific influences. Moreover, the demonstrated function of BCO2 in inhibiting oxidative stress indicated that BCO2 could be associated with the lower damage and oxidative stress to mitochondria in retinal pigment epithelium. 50 Variants of BCO2 might also be associated with AMD through mechanisms involving an impact on the activity of the enzymes involved in inflammation and lipid homeostasis. 51, 52 One of these common variants, rs2115763 in BCO2, is weakly linked with rs2250417, which was also reported to be related to AMD in this study. 34, 49 
Knock down of BCO2 causes anemia and apoptosis of blood cells
To further understand the importance of BCO2 in development, antisense morpholino oligonucleotides were used to knock down the BCO2 gene in zebrafish. 53 No defects in growth pattern or obvious malformations of organ systems, such as eyes and brain, were observed in BCO2 knock down morphants. 54 However, the red blood cells in BCO2 knock down morphants were no longer red and the blood filling rate of the heart was also reduced in BCO2 knock down morphants compared with wild type groups. All these results showed that knock down of BCO2 caused anemia. Although the primitive erythropoiesis was not affected in BCO2 knock down morphants, the expression of a later erythrocyte differentiation marker, embryonic a-globin (hbae3), was increased. During the same time, fragmented nuclei were also presented in erythrocytes of BCO2 knock down morphants, indicating the occurrence of apoptosis of red blood cells. 55, 56 It was also reported that the differentiating blood cells were more sensitive to apoptosis when BCO2 was deficient in zebrafish. Thus, BCO2 is associated with early development of red blood cells in zeabrafish. 54 BCO2 is related to carotenoid-induced oxidative stress Lobo GP and colleagues showed that the protection of cells against apoptosis induced by carotenoids is strictly dependent on BCO2 enzymatic function. 54 After transfecting with the murine BCO2 gene, transfected cells could transiently express BCO2. Compared to control cells, the mitochondrial membrane was more polarized in transfected cells. Intrinsic apoptotic markers were assessed in these transfected cells after treatment with carotenoid. Activated caspase-3, which is a mediator of intrinsic apoptosis, was not changed in the transfected cells compared to control cells. Conversely, knock down of BCO2 in cells caused increased ROS production when cells were treated with carotenoids. More importantly, these BCO2 knock down cells showed an initiation of apoptosis after incubation with carotenoid for 2 hr. 54, 57 Thus, BCO2 expression is inversely associated with cellular oxidative stress. 14
BCO2 is important in prevention of hepatic steatosis
A high fat diet induces hepatic steatosis in mice through a possible mechanism of increasing ROS levels and suppressing mitophagy and mitochondrial biogenesis. The hepatic concentration of zeaxanthin and lutein and the expression of BCO2 in hepatic mitochondria were lowered in mice fed with a high fat diet. These results suggested that BCO2 might be a stress responsive gene in mice. 58 BCO2 knockout mice also showed lipid accumulation in the liver. 14 However, elevated expression of BCO2 attenuated the hepatic steatosis. Knockout of BCO2 might cause mitochondrial dysfunction in the liver, which leads to the impaired fatty acid oxidation and increased hepatic cell susceptibility to oxidative stress. [59] [60] [61] All these results may suggest that the BCO2 protein is important in prevention of hepatic steatosis.
BCO2 status affects dietary Lycopene's impacts on hepatic nuclear receptor-, stress-and metabolism-related gene expression
Lycopene, mainly found in dietary tomato, is one of the most abundant carotenoids in human plasma. Recently, lycopene has attracted more attention because of its impact on a decreased risk of certain chronic diseases, including cancers and cardiovascular diseases. 62 Therefore, large amounts of work have been expended to study the biological properties of lycopene. Within the past few years, apo-lycopenoids, which are the major derivatives of lycopene cleaved by BCO2, were found to present several biological benefits. 63 The lycopene induced effects on nuclear receptor expression was affected by the BCO2 presence. For instance, the tomato diet-induced up-regulation of androgen receptor (Ar) was dependent on the presence of BCO2. Increased hepatic expression of Ar has been linked to lower risk of hepatocellular carcinoma, 64 indicating a role of BCO2-mediated expression of hepatic Ar by dietary tomato. Lycopene-induced down-regulation of seven nuclear receptors was also dependent on BCO2 status. The impacted nuclear receptors and coactivators play diverse roles, including mitochondrial metabolism (Ppargc1b), 65 carcinogenesis (Nr3c1, Esrra), 66 liver metabolic regulation (Esrra), 67 inflammation and immunity (Nr3c1), 68 gene transcription silencing by histone deacetylation (Hdac3), heme-mediated transcription repression (Nr1d2) 69 and mediation of steroid receptor-driven gene transcription (Ncoa2 and Ncoa4). The effect of lycopene diet on metabolism-and stress-related genes was also related to BCO2. However, the pattern is not consistent with the nuclear receptor-related genes. 30, 70 Summary and future prospective Xiangdong Wang, Johannes von Lintig, etc. have demonstrated that BCO2 plays an important role in the metabolism of nonprovitamin A carotenoids, such as lycopene, lutein, and zeaxanthin. 18, 19 BCO2 catalyzes these nonprovitamin A carotenoids through asymmetric cleavage at 9, 10 and/or 9 0 , 10 0 double bond and metabolites. 18, 19 Genetic evidence suggests that BCO2 mutation is associated with yellow skin, fat tissue, and milk in livestock. Human genetic study shows that mutation in intron 2 of BCO2 gene may be related to the IL-18, a pro-inflammatory cytokine associated with various types of human diseases, including obesity, cardiovascular diseases, and type 2 diabetes. 37 Furthermore, BCO2 may play important roles in the development of mitochondrial oxidative stress, 14 macular degeneration, 49 anemia, 54 and hepatic steatosis. 71 Carotenoids, such as zeaxanthin, lutein and their metabolites, meso-zeaxanthin, are macular pigments of human retina, which are known to function as antioxidant and light-screening players in nature. [72] [73] [74] The chemical and spatial accumulation of high levels of xanthophylls in the retina is a specific feature of primates in contrast to other mammals, but the biochemical mechanism for this unique feature is unclear. 5, 75, 76 To better understand the underlying mechanism, it is hypothesized that BCO2 is not expressed, or inactive in primates' retina. However, studies have already shown that BCO2 is expressed in both human and mouse retina. Therefore, the enzyme activity of human BCO2 was investigated by cell-based carotenoid cleavage assay. According to this study, BCO2 was shown to be an inactive carotenoid cleavage enzyme. Another study showed that xanthophylls carotenoids are highly uptaken by human ARPE-19 cells, although no cleavage products of xanthophyll were found in these cells. 77 Moreover, no eccentric cleavage products were found when human subjects were given labeled supplements of b-carotene. 78, 79 No association between human BCO2 SNPs and optical density of macular pigment was reported, which also implies that human BCO2 cannot catalyze macular pigments. Moreover, human BCO2 was demonstrated to be unable to bind with appropriate carotenoid substrates in the active site. This might be another reason that human BCO2 is inactive in the human retina. However, Johannes von Lintig and colleagues provided evidence that the enzymatic function of BCO2 is conserved in primates. Therefore, it is still controversial about the enzymatic activity of BCO2 in humans. 40, 80 We are still at the early stage of understanding the importance of BCO2 in health and disease. As BCO2 is located in the inner mitochondrial membrane, 16 BCO2 might impact on normal mitochondrial function through targeting the ETC/OXPHOS, including inhibiting the activity of different complexes, increasing the proton leak or decreasing the ATP production efficiency. As discussed above, knockout of BCO2 in the liver could increase the production of ROS. 14 Recently , it has been proposed that mitochondria could prevent the ROS production through forming supercomplexes. 81 There is accumulating evidence demonstrating that mitochondrial respiratory chain complexes associated with formation of different supermolecules, known as supercomplexes. 82, 83 Recent evidence supports the function of these supercomplexes, including: (1) the formation of mitochondrial respiratory chain supercomplexes could minimize the production of ROS which is generated from complex I, 81 (2) the mitochondrial respiratory chain supercomplexes may intergrate the cytochrome c and coenzyme Q to induce a kinetic advantage via facilitating efficient transportation of electrons through substrate channeling, 84 (3) mammalian complex I is assembled in mitochondrial respiratory chain supercomplexes, which help to stabilize the complex I. 85, 86 It would therefore be interesting to investigate the association between BCO2 and the formation of mitochondrial respiratory chain supercomplexes. This might provide an explanation for why BCO2 knockout could cause increased ROS production.
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